-
) the University Medical Centre Hamburg-Eppendorf and University of Kassel in Germany. Despite the success of immune checkpoint therapy (ICT) less than 30 % of patients with established solid tumors benefit from
-
. Bosch Centre for Artificial Intelligence , Germany is a partner of this call, and will fund and employ candidates for two of the projects. All of the recruited candidates will be part of the Integreat
Searches related to Germany
Enter an email to receive alerts for Germany positions